focus -WSS

focus

author：focus 2025-09-27 09:46:57 - browse：3

Priscilla Chan and Mark Zuckerberg on stage, virtually, at the 2023 STAT Summit. STAT

Mark Zuckerberg and Priscilla Chan sit atop a fortune that is currently valued at $113 billion, and they’ve promised to give almost all of it away. Their philanthropic funding group, the Chan Zuckerberg Initiative, is committed to investing in an array of fields, including science, education, housing insecurity, and expanding access to startup capital to entrepreneurs of color.

In 2015, when the self-described science nerds pledged 99 percent of their Facebook fortune to philanthropic causes over their lifetimes, they did not specify how they might spread their wealth. But at the STAT Summit on Wednesday, the couple went further in describing their goals, doubling down on science.

“The science piece is a huge, huge part of that,” Zuckerberg said when asked about his spending plans. “I would imagine that if the company continues doing well that we will have $50 billion or more over time to put into this kind of work, but we want that to compound and grow over time as we get more confidence in the model.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Amazon on where the company's health care bets are headed next

leisure time

WSS

How to protect patients from sexual assault

The 10 drugs up first for Medicare price negotiation

FDA sets aggressive timeline for overhauling inspection procedures

Seth Rogen and Lauren Miller Rogen on Alzheimer's caregiving

AstraZeneca chief proposes a novel edit to the drug pricing bill

Dana Farber says 6 studies to be retracted and 31 corrected

knowledge

focus

focus

Heart attack and stroke risk calculators need revising

Medicare drug price lawsuits could be good politics for Biden

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

AstraZeneca chief proposes a novel edit to the drug pricing bill

Supreme Court strikes down use of affirmative action

The (many) problems with a new study criticizing cancer screening

The cancer drug shortage isn’t new — and neither are the solutions

Medicare bonuses could stop drug shortages under Senate plan

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Covid hospitalizations on the rise, Humana says

knowledge

Inaction leaves children at risk from dangerous chemotherapy drug

What drug price negotiations mean for Medicare Part D

FDA sets aggressive timeline for overhauling inspection procedures

Microsoft launches AI tool for clinical documentation through Epic

FDA endorses new sterilization method for medical devices

What causes osteoarthritis? Researchers study link to brain protein

knowledge

leisure time

hotspot

hotspot